• Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications
  • Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications

Jour : 13 mars 2026

New Study Demonstrates PredictCan’s Individual-Centric Approach to DILI Prediction

Published in Frontiers in Toxicology in collaboration with Centre Antoine Lacassagne, the study demonstrates how PredictCan’s human serum-derived liver models combined with AI can capture chronic and individual-specific DILI while providing clinically relevant risk classification and mechanistic insights.

PredictCan_Logo_01
  • Privacy Policy
  • Legal Notice
  • Privacy Policy
  • Legal Notice

Follow us

Linkedin Twitter

© 2026 - predictcan | Tous Droits Réservés

By JCD Groupe

  • Home
  • Company
    • Our Vision
    • Our Team
    • Partners
  • Technology
  • Applications
    • Drug Safety
    • Drug efficacy
    • Our Services
      • DishTrial4LiverTox™
      • DishTrial4OncoEfficacy™
  • Work With Us
  • News
  • Publications
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.